PDF
Abstract
The steady increase in bariatric surgery has led to room for innovation. Endoscopy has become an important tool for evaluation, diagnosis, management of complications, and even for primary bariatric interventions. Leaks are the most feared complication and new endoscopic therapies have been developed such as septotomy, double-pigtail stents, and endoscopic vacuum therapy. Additionally, primary bariatric endoscopic procedures are gaining popularity and the new procedures include intragastric balloons, stoma reduction, aspiration therapy, among others. The altered anatomy and reoperation increase the risk of complications after bariatric surgery, especially when managing conditions like achalasia, gastroparesis, and cholelithiasis. Per-oral endoscopic myotomy, per-oral pyloromyotomy, and endoscopic ultrasound-guided transgastric endoscopic retrograde cholangiopancreatography provide a less invasive approach to address these conditions. This narrative review article intends to expose current endoscopic therapies for the management of primary bariatric procedures, complications and related conditions.
Keywords
Endoscopy
/
bariatric surgery
/
septotomy
/
leaks
/
endosuturing
/
intragastric balloons
/
per-oral pyloromyotomy
/
per-oral endoscopy myotomy
Cite this article
Download citation ▾
Melissa Castro, Alfredo Daniel Guerron.
Bariatric endoscopy: current primary therapies and endoscopic management of complications and other related conditions.
Mini-invasive Surgery, 2020, 4(1): 47 DOI:10.20517/2574-1225.2020.14
| [1] |
World Health Organization. Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. [Last accessed on 29 Jul 2020]
|
| [2] |
Guerron AD,Lee HJ,Ingram J.Asthma medication usage is significantly reduced following bariatric surgery..Surg Endosc2019;33:1967-75 PMCID:PMC6686182
|
| [3] |
ASMBS. Estimate of Bariatric Surgery Numbers, 2011-2018. Available from: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers#. [Last accessed on 29 Jul 2020]
|
| [4] |
Angrisani L,Iovino P,Higa K.IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures..Obes Surg2018;28:3783-94
|
| [5] |
Fernández-Soto ML,González-Jiménez A,Cózar-Ibáñez A.Remission of type 2 diabetes mellitus after bariatric surgery - comparison between procedures..Endokrynol Pol2017;68:18-25
|
| [6] |
Singh AK,Kota SK.Bariatric surgery and diabetes remission: Who would have thought it?.Indian J Endocrinol Metab2015;19:563-76 PMCID:PMC4566335
|
| [7] |
Ryou M,Thompson CC.Current status of endoluminal bariatric procedures for primary and revision indications..Gastrointest Endosc Clin N Am2011;21:315-33 PMCID:PMC3460649
|
| [8] |
Gollisch KSC.Endoscopic intragastric balloon: a gimmick or a viable option for obesity?.Ann Transl Med2020;8:S8 PMCID:PMC7154325
|
| [9] |
Papademetriou M.Intragastric balloons in clinical practice..Gastrointest Endosc Clin N Am2017;27:245-56
|
| [10] |
Ashrafian H,Braby TS,Bonanomi G.Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series..Surg Obes Relat Dis2018;14:1691-9
|
| [11] |
Moore RL,Garber SM,Nguyen RT.Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization..Surg Obes Relat Dis2019;15:417-23
|
| [12] |
Yorke E,Reso A,de Gara C.Intragastric balloon for management of severe obesity: a systematic review..Obes Surg2016;26:2248-54
|
| [13] |
Sullivan S.Aspiration therapy for obesity..Gastrointest Endosc Clin N Am2017;27:277-88
|
| [14] |
Sullivan S,Thompson CC.Endoscopic bariatric and metabolic therapies: new and emerging technologies..Gastroenterology2017;152:1791-801
|
| [15] |
Sullivan S,Jonnalagadda S,Edmundowicz S.Aspiration therapy leads to weight loss in obese subjects: a pilot study..Gastroenterology2013;145:1245-52.e1-5 PMCID:PMC4025911
|
| [16] |
Thompson CC,Kushner R,Schorr AB.Percutaneous gastrostomy device for the treatment of Class II and Class III obesity: results of a randomized controlled trial..Am J Gastroenterol2017;112:447-57 PMCID:PMC5350543
|
| [17] |
Nyström M,Norén E,Janssen I.Aspiration therapy as a tool to treat obesity: 1- to 4-year results in a 201-Patient Multi-Center Post-Market European Registry Study..Obes Surg2018;28:1860-8 PMCID:PMC6018576
|
| [18] |
Goyal D.Endoscopic bariatric therapies..Curr Gastroenterol Rep2016;18:26
|
| [19] |
Abu Dayyeh BK,Jonnalagadda S,Larsen M.ASGE Bariatric Endoscopy Task Force; ASGE Technology Committee, Endoscopic bariatric therapies..Gastrointest Endosc2015;81:1073-86
|
| [20] |
Rodriguez-Grunert L,Alamo M,Baez PB.First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve..Surg Obes Relat Dis2008;4:55-9
|
| [21] |
Escalona A,Sharp A,Slako M.Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner..Ann Surg2012;255:1080-5
|
| [22] |
Sandler BJ,Swain CP,Morales L.One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity..Surg Endosc2015;29:3298-303
|
| [23] |
Marinos G, Eliades C, Muthusamy R, Iki K, Kline C, et al. First clinical experience with the transpyloric shuttle (TPS(R)) device, a non-surgical endoscopic treatment for obesity: results from a 3-month and 6-month study: Abstract 2013. Available from: https://www.sages.org/meetings/annual-meeting/abstracts-archive/first-clinical-experience-with-the-transpyloric-shuttle-tpsr-device-a-non-surgical-endoscopic-treatment-for-obesity-results-from-a-3-month-and-6-month-study/. [Last accessed on 3 Aug 2020]
|
| [24] |
Giuliani A,Marchese M,Cianca G.Gastric leak after laparoscopic sleeve gastrectomy: management with endoscopic double pigtail drainage. A systematic review..Surg Obes Relat Dis2019;15:1414-9
|
| [25] |
Diaz R,Welsh LK,Guerron AD.Use of magnets in gastrointestinal surgery..Surg Endosc2019;33:1721-30
|
| [26] |
Ryou M,Thompson CC.Minimally invasive entero-enteral dual-path bypass using self-assembling magnets..Surg Endosc2016;30:4533-8
|
| [27] |
Machytka E,Zonca P,Ryou M.Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes..Gastrointest Endosc2017;86:904-12
|
| [28] |
van Baar ACG,Crenier L,Magee C.Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study..Gut2020;69:295-303 PMCID:PMC6984054
|
| [29] |
Rajagopalan H,Thompson CC,Rubino F.Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study..Diabetes Care2016;39:2254-61
|
| [30] |
Lopez-Nava G,Bautista-Castaño I,Trell M.Endoscopic sleeve gastroplasty for obesity treatment: two years of experience..Arq Bras Cir Dig2017;30:18-20 PMCID:PMC5424680
|
| [31] |
Barrichello S,Hourneaux de Moura EG,Hoff AC.Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study..Gastrointest Endosc2019;90:770-80
|
| [32] |
Eslick GD.Prevalence and epidemiology of gastrointestinal symptoms among normal weight, overweight, obese and extremely obese individuals..Gastroenterol Clin North Am2010;39:9-22
|
| [33] |
Evans JA,Acosta RD,Chandrasekhara V.American Societyfor Gastrointestinal Endoscopy Standards of Practice. The role of endoscopy in the bariatric surgery patient..Gastrointest Endosc2015;81:1063-72
|
| [34] |
Plevin R,Marriott DB,Boarder MR.Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells..J Pharmacol Exp Ther1990;252:1296-303
|
| [35] |
Hernández J.Novel treatments for complications after bariatric surgery..Ann Surg Innov Res2016;10:3 PMCID:PMC4791794
|
| [36] |
De Palma GD.Role of endoscopy in the bariatric surgery of patients..World J Gastroenterol2014;20:7777-84 PMCID:PMC4069306
|
| [37] |
Ortega CB,Portenier D.Endoscopic abscess septotomy: a less invasive approach for the treatment of sleeve gastrectomy leaks..J Laparoendosc Adv Surg Tech A2018;28:859-63
|
| [38] |
Guerron AD,Portenier D.Endoscopic abscess septotomy for management of sleeve gastrectomy leak..Obes Surg2017;27:2672-4
|
| [39] |
Shnell M,Abu-Abeid S,Fishman S.Use of endoscopic septotomy for the treatment of late staple-line leaks after laparoscopic sleeve gastrectomy..Endoscopy2017;49:59-63
|
| [40] |
Guerron AD,Portenier D. Anastomotic leak following gastric bypass. In: Camacho D, Zundel N, editors. Complications in bariatric surgery. Springer; 2018. pp. 77-84. Available from: https://scholars.duke.edu/publication/1354537. [Last accessed on 3 Aug 2020]
|
| [41] |
Guerron AD,Kroh M.Rogula TG,Fouse T.Endoscopic management of complications: bleeding, leaks, and strictures..Prevention and Management of complications in bariatric surgery.2018;Oxford University
|
| [42] |
Rodrigues-Pinto E,Donatelli G,Devière J.International multicenter expert survey on endoscopic treatment of upper gastrointestinal anastomotic leaks..Endosc Int Open2019;7:E1671-82 PMCID:PMC6877414
|
| [43] |
Mahadev S,Campos JM,Khashab MA.Endoscopic septotomy: an effective approach for internal drainage of sleeve gastrectomy-associated collections..Endoscopy2017;49:504-8
|
| [44] |
Campos JM,Teixeira AF,Moon RC.Septotomy and balloon dilation to treat chronic leak after sleeve gastrectomy: technical principles..Obes Surg2016;26:1992-3
|
| [45] |
Diaz R,Perez JE,Davalos G.Endoscopic septotomy as a treatment for leaks after sleeve gastrectomy: Meeting presentations: Digestive Disease Week 2019..Endosc Int Open2020;8:E70-5 PMCID:PMC6949161
|
| [46] |
Archid R,Klingert W,Hönes F.Endoscopic vacuum therapy for staple line leaks after sleeve gastrectomy..Obes Surg2020;30:1310-5
|
| [47] |
Rodrigues-Pinto E,Vilas-Boas F,Macedo G.Role of endoscopic vacuum therapy, internal drainage, and stents for postbariatric leaks..VideoGIE2019;4:481-5 PMCID:PMC6831905
|
| [48] |
Kumar N.Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration..World J Gastrointest Endosc2015;7:847-59 PMCID:PMC4515419
|
| [49] |
Schulman AR,Thompson CC.Transoral outlet reduction: a comparison of purse-string with interrupted stitch technique..Gastrointest Endosc2018;87:1222-8 PMCID:PMC5899924
|
| [50] |
Jirapinyo P,AlSamman MA.Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass..Gastrointest Endosc2020;91:1067-73 PMCID:PMC7183415
|
| [51] |
Horgan S,Weiss GD,Denk PM.Incisionless revision of post-Roux-en-Y bypass stomal and pouch dilation: multicenter registry results..Surg Obes Relat Dis2010;6:290-5
|
| [52] |
Ukleja A,Pimentel R,Rosenthal R.Outcome of endoscopic balloon dilation of strictures after laparoscopic gastric bypass..Surg Endosc2008;22:1746-50
|
| [53] |
Parikh A,Peterson RM,Pfluke JM.Management options for symptomatic stenosis after laparoscopic vertical sleeve gastrectomy in the morbidly obese..Surg Endosc2012;26:738-46
|
| [54] |
Bashir U,Gerke H,Parekh K.Peroral endoscopic myotomy is feasible and safe in a gastric bypass population..Obes Surg2019;29:3523-6
|
| [55] |
Inoue H,Kobayashi Y,Kaga M.Peroral endoscopic myotomy (POEM) for esophageal achalasia..Endoscopy2010;42:265-71
|
| [56] |
Costantini A,Costantini M,Valmasoni M.Poem versus laparoscopic heller myotomy in the treatment of esophageal achalasia: a case-control study from two high volume centers using the propensity score..J Gastrointest Surg2020;24:505-15
|
| [57] |
Ngamruengphong S,Ujiki MB,Bapaye A.Efficacy and safety of peroral endoscopic myotomy for treatment of achalasia after failed heller myotomy..Clin Gastroenterol Hepatol2017;15:1531-7.e3
|
| [58] |
Fernandez-Ananin S,Balagué C,Targarona EM.What to do when Heller’s myotomy fails? Pneumatic dilatation, laparoscopic remyotomy or peroral endoscopic myotomy: a systematic review..J Minim Access Surg2018;14:177-84 PMCID:PMC6001296
|
| [59] |
Sanaei O,Kunda R,Khashab MA.Peroral endoscopic myotomy for the treatment of achalasia patients with Roux-en-Y gastric bypass anatomy..Endoscopy2019;51:342-5
|
| [60] |
Luo RB,Horgan S.Peroral endoscopic myotomy after gastric bypass: An effective solution for de novo achalasia..Surg Obes Relat Dis2017;13:e1-3
|
| [61] |
Xu J,Elkholy S,Zhong Y.Gastric peroral endoscopic myotomy (G-POEM) as a treatment for refractory gastroparesis: long-term outcomes..Can J Gastroenterol Hepatol2018;2018:6409698 PMCID:PMC6217887
|
| [62] |
Strong AT,Kroh M,Cline M.Safety and feasibility of per-oral pyloromyotomy as augmentative therapy after prior gastric electrical stimulation for gastroparesis..J Am Coll Surg2019;229:589-95
|
| [63] |
Rodriguez J,Haskins IN,Allemang MT.Per-oral pyloromyotomy (POP) for medically refractory gastroparesis: short term results from the first 100 patients at a high volume center..Ann Surg2018;268:421-30
|
| [64] |
Farha J,Kadhim A,Badurdeen DS.Gastric per-oral endoscopic myotomy (G-POEM) for the treatment of gastric stenosis post-laparoscopic sleeve gastrectomy (LSG)..Obes Surg2019;29:2350-4
|
| [65] |
Kedia P,Nieto J,Siddiqui A.EUS-directed transgastric ERCP (EDGE) versus laparoscopy-assisted ERCP (LA-ERCP) for Roux-en-Y gastric bypass (RYGB) anatomy: a multicenter early comparative experience of clinical outcomes..J Clin Gastroenterol2019;53:304-8
|
| [66] |
Tyberg A,Salgado S,Kedia P.Endoscopic ultrasound (EUS)-directed transgastric endoscopic retrograde cholangiopancreatography or EUS: mid-term analysis of an emerging procedure..Clin Endosc2017;50:185-90 PMCID:PMC5398356
|